446 related articles for article (PubMed ID: 11786976)
1. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages.
Rosen HR; Miner C; Sasaki AW; Lewinsohn DM; Conrad AJ; Bakke A; Bouwer HG; Hinrichs DJ
Hepatology; 2002 Jan; 35(1):190-8. PubMed ID: 11786976
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of viral clearance and CD4(+) T-cell response in acute hepatitis C primary infection and reinfection.
Aberle JH; Formann E; Steindl-Munda P; Weseslindtner L; Gurguta C; Perstinger G; Grilnberger E; Laferl H; Dienes HP; Popow-Kraupp T; Ferenci P; Holzmann H
J Clin Virol; 2006 May; 36(1):24-31. PubMed ID: 16483838
[TBL] [Abstract][Full Text] [Related]
3. In vitro activation and differentiation of naïve CD4+ and CD8+ T cells into HCV core- and NS3-specific armed effector cells: a new role for CD4+ T cells.
Krishnadas DK; Li W; Kumar R; Tyrrell LJ; Agrawal B
Cell Immunol; 2009; 259(2):141-9. PubMed ID: 19616202
[TBL] [Abstract][Full Text] [Related]
4. Virus-specific effector CD4+ T-cell responses in hemodialysis patients with hepatitis C virus infection.
Rico MA; Ruiz S; Subirá D; Barril G; Cigarrán S; Castañón S; Quiroga JA; Selgas R; Carreño V
J Med Virol; 2004 Jan; 72(1):66-74. PubMed ID: 14635013
[TBL] [Abstract][Full Text] [Related]
5. Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors.
Scognamiglio P; Accapezzato D; Casciaro MA; Cacciani A; Artini M; Bruno G; Chircu ML; Sidney J; Southwood S; Abrignani S; Sette A; Barnaba V
J Immunol; 1999 Jun; 162(11):6681-9. PubMed ID: 10352286
[TBL] [Abstract][Full Text] [Related]
6. Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C.
Penna A; Missale G; Lamonaca V; Pilli M; Mori C; Zanelli P; Cavalli A; Elia G; Ferrari C
Hepatology; 2002 May; 35(5):1225-36. PubMed ID: 11981773
[TBL] [Abstract][Full Text] [Related]
7. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
[TBL] [Abstract][Full Text] [Related]
8. Cellular immune responses and occult infection in seronegative heterosexual partners of chronic hepatitis C patients.
Roque-Cuéllar MC; Sánchez B; García-Lozano JR; Praena-Fernández JM; Núñez-Roldán A; Aguilar-Reina J
J Viral Hepat; 2011 Oct; 18(10):e541-9. PubMed ID: 21914075
[TBL] [Abstract][Full Text] [Related]
9. Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behcet's disease.
Koarada S; Haruta Y; Tada Y; Ushiyama O; Morito F; Ohta A; Nagasawa K
Rheumatology (Oxford); 2004 Jul; 43(7):843-51. PubMed ID: 15150429
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive longitudinal analysis of hepatitis C virus (HCV)-specific T cell responses during acute HCV infection in the presence of existing HIV-1 infection.
van den Berg CH; Ruys TA; Nanlohy NM; Geerlings SE; van der Meer JT; Mulder JW; Lange JA; van Baarle D
J Viral Hepat; 2009 Apr; 16(4):239-48. PubMed ID: 19222746
[TBL] [Abstract][Full Text] [Related]
11. A novel assay for detection of hepatitis C virus-specific effector CD4(+) T cells via co-expression of CD25 and CD134.
Keoshkerian E; Helbig K; Beard M; Zaunders J; Seddiki N; Kelleher A; Hampartzoumian T; Zekry A; Lloyd AR
J Immunol Methods; 2012 Jan; 375(1-2):148-58. PubMed ID: 22019644
[TBL] [Abstract][Full Text] [Related]
12. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
[TBL] [Abstract][Full Text] [Related]
13. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.
Cabrera R; Tu Z; Xu Y; Firpi RJ; Rosen HR; Liu C; Nelson DR
Hepatology; 2004 Nov; 40(5):1062-71. PubMed ID: 15486925
[TBL] [Abstract][Full Text] [Related]
14. Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response.
Pilli M; Penna A; Zerbini A; Vescovi P; Manfredi M; Negro F; Carrozzo M; Mori C; Giuberti T; Ferrari C; Missale G
Hepatology; 2002 Dec; 36(6):1446-52. PubMed ID: 12447871
[TBL] [Abstract][Full Text] [Related]
15. Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence.
Golden-Mason L; Burton JR; Castelblanco N; Klarquist J; Benlloch S; Wang C; Rosen HR
Hepatology; 2006 Nov; 44(5):1098-109. PubMed ID: 17058243
[TBL] [Abstract][Full Text] [Related]
16. HCV-NS3 Th1 minigene vaccine based on invariant chain CLIP genetic substitution enhances CD4(+) Th1 cell responses in vivo.
Gao M; Wang HP; Wang YN; Zhou Y; Wang QL
Vaccine; 2006 Jun; 24(26):5491-7. PubMed ID: 16725235
[TBL] [Abstract][Full Text] [Related]
17. Differential antigenic hierarchy associated with spontaneous recovery from hepatitis C virus infection: implications for vaccine design.
Smyk-Pearson S; Tester IA; Lezotte D; Sasaki AW; Lewinsohn DM; Rosen HR
J Infect Dis; 2006 Aug; 194(4):454-63. PubMed ID: 16845628
[TBL] [Abstract][Full Text] [Related]
18. CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes.
Woitas RP; Lechmann M; Jung G; Kaiser R; Sauerbruch T; Spengler U
J Immunol; 1997 Jul; 159(2):1012-8. PubMed ID: 9218624
[TBL] [Abstract][Full Text] [Related]
19. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection.
Hoffmann RM; Diepolder HM; Zachoval R; Zwiebel FM; Jung MC; Scholz S; Nitschko H; Riethmüller G; Pape GR
Hepatology; 1995 Mar; 21(3):632-8. PubMed ID: 7875660
[TBL] [Abstract][Full Text] [Related]
20. Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C.
Schupper H; Hayashi P; Scheffel J; Aceituno S; Paglieroni T; Holland PV; Zeldis JB
Hepatology; 1993 Nov; 18(5):1055-60. PubMed ID: 7693570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
